Recombinant Human HLA class I histocompatibility antigen, alpha chain E(HLA-E) ,partial

In Stock
Code CSB-EP320269HU
Size US$1103Purchase it in Cusabio online store
(only available for customers from the US)
  • (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity Greater than 90% as determined by SDS-PAGE.
Target Names HLA-E
Uniprot No. P13747
Research Area Immunology
Alternative Names HLA-E; HLA-6.2; HLAEHLA class I histocompatibility antigen; alpha chain E; MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen; alpha chain E; sHLA-E)]
Species Homo sapiens (Human)
Source E.coli
Expression Region 22-305aa
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Mol. Weight 48.7kDa
Protein Length Extracellular Domain
Tag Info N-terminal 6xHis-SUMO-tagged
Form Liquid or Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
Note: If you have any special requirement for the glycerol content, please remark when you place the order.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference.
and FAQs
Protein FAQs
Storage Condition Store at -20°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time Basically, we can dispatch the products out in 3-7 working days after receiving your orders. Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Notes Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA Please contact us to get it.

Q&A and Customer Reviews


1.Is the 6xHis-SUMO tag retained or is it cleaved after your expression?
2.Has this molecule been shown to bind to anti-HLA-E and anti-HLA-ABC (pan class I) antibodies?

Thanks for your inquiry.1. If you needs to remove the tag, please communicate with us in advance, otherwise, we won't remove the tag. Not all protein tags can be removed as some proteins will be very unstable after tag removal. If we succeed in removing the tag, we will charge for extra cost.
If we fail in removing the tag, we won’t charge for any extra cost, and remark this information in datasheet as follows “Note: The laboratory determined that the Tag on your protein could not be removed with standard laboratory procedures. Your protein is being supplied with the Tag intact.”
Generally, the delivery time will be extended for 2-3 days.
2. This protein can bind to anti-HLA-E and anti-HLA-ABC (pan class I) antibodies in theory, but we haven't performed relevant validation. It is suggested that antibodies and antigens are derived from the same recombinant expression system, because the conformation of proteins expressed by different recombinant expression systems will be different, which may lead to difference in recognition.

I hope this email finds you well. I am interested in this protein but they would like to know more information regarding its biological activity. Is this information available for me to share?

Very nice to receive your inquiry.
We haven't tested the biological activity of this protein. The protein we provide is the complete extracellular domain purified under mild conditions which should have activity in theory.
This protein has been delivered for many times. Any more questions, feel free to contact us.

Target Data

Function Preferably binds to a peptide derived from the signal sequence of most HLA-A, -B, -C and -G molecules.
Gene References into Functions
  1. Data suggest that, although different T-cell receptors adopt distinct docking modes on HLAE, energetic basis of T-cell receptor interaction is defined by set of conserved HLAE residues. PMID: 28972140
  2. It indicates that HLA-E expression may have an immunomodulatory effect and a possible role in the severity of liver disease in chronic hepatitis C. PMID: 29951556
  3. HLA-E is highly represented in ovarian carcinoma suggesting a potential association with progressive disease mechanism PMID: 29499226
  4. Soluble HLA-E level is useful as a biomarker of disease activity and course in Takayasu arteritis patients. rs1264457 polymorphism is neither associated with susceptibility nor did it influence sHLA-E levels in TA. PMID: 28425192
  5. The frequency of the HLA-E*0101/*0103X genotype in male patients with Pemphigus Vulgaris was found to be significantly higher than in men in the control group (P=0.023). PMID: 29252170
  6. These data suggest that HLA-E overexpression frequently occurs in renal cell carcinoma and correlates with reduced immunogenicity PMID: 27589686
  7. HLA-E restricted CD8+ T cells may represent an important subset of pTregs, suppressing previously activated target cells. PMID: 24144875
  8. No specific HLA-G and HLA-E haplotypes were significantly associated with increased risk of developing severe preeclampsia/eclampsia. PMID: 27596021
  9. Our findings provide evidence that during renal allograft rejection HLA-E along with high numbers of mismatched HLA-class I leader peptides might represent additional targets for immune-activating responses. PMID: 27871782
  10. The results suggest that HLA-E allelic variants may play a role in the modulation of immune responses in the context of the inability of natural conception and establishment of a viable pregnancy. PMID: 27714943
  11. The prognostic benefit of natural killer cells, but not T-cells, is influenced by HLA-E expression in endometrial cancer. PMID: 29059634
  12. This data reinforces the presence of only two main full-length HLA-E molecules encoded by the many HLA-E alleles detected in our population sample. In addition, this data does indicate that the distal HLA-E promoter is by far the most variable segment. PMID: 28946074
  13. HLA-E alleles and sHLA-E levels may represent novel biomarkers for early disease progression in patients with chronic lymphocytic leukemia PMID: 27859015
  14. In insulitic islets from living patients with recent-onset T1D, most of the overexpressed ISGs, including GBP1, TLR3, OAS1, EIF2AK2, HLA-E, IFI6, and STAT1, showed higher expression in the islet core compared with the peri-islet area containing the surrounding immune cells PMID: 27422384
  15. soluble HLA-Ib molecules HLA-G and HLA-E are present in BM plasma samples in physiological and pathological conditions, and their concentration correlated with stage disease in NB patients. PMID: 27610393
  16. this study shows the high expression of HLA-E in actinic chelitis and in lip squamous cell carcinoma, which reflects the capacity that these pathologies have for evasion and progression PMID: 26723902
  17. Our study reveals that HLA-E polymorphism is associated with nasopharyngeal cancer. PMID: 26896927
  18. High expression of HLA-E is associated with non-small cell lung carcinoma. PMID: 26658106
  19. The positive correlation has been found between the HLA-E*01:01/01:03 A>G polymorphism, plasma HLA-E level, and advanced fibrosis stages in chronic hepatitis B patients. PMID: 26956431
  20. the promoter region of the HLA-E gene presents few and rare variable sites in Brazilian population sample. PMID: 26596885
  21. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire PMID: 26382247
  22. HLA-E is capable of presenting a highly conserved peptide from HIV-1 capsid (AISPRTLNA) that is not recognized by NKG2A/CD94. PMID: 26828202
  23. over-expression of HLA-E is associated with melanoma PMID: 26090591
  24. Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype. PMID: 25735891
  25. this study suggests that minor histocompatibility antigens presented by HLA-E can represent an additional risk factor following lung transplantation. PMID: 26302084
  26. These results indicate that E*01:01 is a novel protective genetic factor in EBV-associated cHL and support a role for HLA-E recognition on the control of EBV infection and lymphomagenesis. PMID: 26261988
  27. HLA-E molecules traffic differently from the HLA-class I molecules and can play a fundamental role in the protection against intracellular pathogens and susceptibility to several diseases. PMID: 26310830
  28. Functional differences and the immunological impact of HLA-E allelic variant Arg107Gly PMID: 26552660
  29. increased risk of recurrent miscarriage in mothers carrying HLA-E*01:01 allele; meta-analysis PMID: 25700963
  30. The results derived from this study imply that HLA-E polymorphisms may influence RA susceptibility and affect clinical outcome of anti-TNF therapy in female RA patients. PMID: 26307125
  31. genetic polymorphism is not associated with nasopharyngeal carcinoma in China PMID: 25636564
  32. genetic polymorphism does not affect treatment outcome following allogeneic hematopoietic stem cell transplantation in Egyptian patients PMID: 25543014
  33. Monoclonal antibodies to HLA-E bind epitopes carried by unfolded beta2 m-free heavy chains. PMID: 25982269
  34. We identified that the HLA-E and HLA-F in gastric cancer independently affected clinical factors, including postoperative outcome PMID: 25862890
  35. HLA-E gene polymorphisms are associated with the development of breast cancer in women of Han polulation. PMID: 25854574
  36. HLA-E*0103 allele is associated with susceptibility to serous ovarian cancer in a Chinese Han population. PMID: 25711417
  37. Review of the impact of human leukocyte antigen molecules E, F, and G on the outcome of transplantation. PMID: 25420801
  38. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. PMID: 25384219
  39. novel insights in the mechanism via which HLA-E expression levels are controlled and how the cellular immune response in transplantation and cancer is influenced by HLA-E. PMID: 25413103
  40. Results show that HLA-E and KIR2DL4 demonstrate evidence of positive selection between human, chimpanzee and gorilla suggesting a main role for immunological adaptations linked to embryo deep invasion of the maternal endometrium during pregnancy. PMID: 25451741
  41. Studies suggest that HLA class I molecule HLA-E to be a ligand for the innate and adaptive immune system. PMID: 25401109
  42. Sera from early-onset, severely preeclamptic women directly modulate HLA-E expression in the EA.hy296 endothelial cell line. PMID: 24837231
  43. Findings indicate that HLA-E up-regulation in 3D-cultured cells may result in enhanced tumor resistance to NK cell-mediated immune response. PMID: 24742303
  44. The expression levels of HLA-G or HLA-E alone and the combined expression of both molecules were all statistically correlated with the overall survival of colorectal cancer patients. PMID: 25461612
  45. Transgenic hCD46/HLA-E expression reduced humoral xenoresponses since all were downregulated during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood. PMID: 24635052
  46. IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-gamma release by autologous NK cells. PMID: 24741633
  47. NKG2C receptor deletion and a functional polymorphism in its ligand HLA-E may play a role in psoriasis susceptibility PMID: 24079744
  48. surface HLA-E was higher on melanoma cells than on melanocytes and protected the former (6/6 cell lines) from lysis by natural killer (NK) cells, functionally counteracting co-expressed triggering ligands. PMID: 24011128
  49. These results indicate that generating transgenic HLA-E pigs might protect porcine grafts from, not only NK cytotoxicity, but also macrophage-mediated cytotoxicity. PMID: 23994719
  50. Data suggest that the cell-surface HLA class I molecules HLA-E, HLA-C, and HLA-G co-localize with each other on trophoblast cell membranes and have the potential to form preferential heterotypic associations that may be modulated by progesterone. PMID: 24006284
  51. Patients with tumours who showed neither HLA class I nor HLA-E or -G expression (phenotype a) had a significant better OS. PMID: 24196788
  52. TFL-033 and MEM-E/02 may distinguish the phenotypic expressions of cell surface HLA-E during stages of tumor progression. PMID: 24105714
  53. Increased soluble HLA-E levels are found in cerebrospinal fluid (CSF) from multiple sclerosis patients. PMID: 23625177
  54. Lack of association has been found between HLA-E polymorphisms and transitional cell carcinoma of the bladder. PMID: 23786553
  55. HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. PMID: 23811951
  56. HLA-E*0103X polymorphism has a role in susceptibility to Pemphigus vulgaris PMID: 23362868
  57. the level of HLA-E expression in tumor tissue strongly predicted long-term survival in in patients with stage III colorectal cancer. PMID: 23377987
  58. a protective role for HLA-E*0103/0103 genotype against relapse and an association between this genotype and an improved DFS following HLA-E matched allogeneic HSCT. PMID: 23395341
  59. A novel HLA-E allele, E*01:03:05, was found in two unrelated Brazilian individuals (a Caucasian female and an Afro-Brazilian male). PMID: 22594712
  60. Increased HLA-E expression in white matter lesions in multiple sclerosis. PMID: 23039207
  61. This study provides further support for involvement of MHC class I molecules in schizophrenia. PMID: 22883433
  62. Mifepristone can inhibit the effects of progesterone by down-regulating the expressions of HLA-G, HLA-E and HLA-F mRNA in trophoblasts during the first trimester. PMID: 22490650
  63. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. PMID: 22927436
  64. HLA-G and HLA-E could represent useful prognostic biomarkers in Renal cell carcinoma PMID: 22640987
  65. Suggest protective role for HLA-E*0103/0103 genotype against acute/chronic graft-versus-host disease. This genotype is associated with better overall survival after HLA-E matched allogeneic hematopoietic stem cell transplantation. PMID: 22427472
  66. Studies indicate that HLA-E interacts with CD94/NKG2 receptors expressed mainly on the surface of natural killer (NK) cells, thus confining its role to the regulation of NK-cell function. PMID: 22576308
  67. we investigate the contribution of the non-classical MHC molecule HLA-E to the immunosuppressive phenotype of glioma-initiating cells PMID: 22688424
  68. these data unraveled the peculiarity in terms of HLA-E allelic and haplotypic repertoire in four main ethnic groups in Mainland China, findings shown here are valuable for future studies of the potential role of HLA-E in allogeneic organ transplantation a PMID: 22486789
  69. Prediction of radiographic severity in Ankolysing Spondylitis based on clinical variables can be significantly improved by including Single Nucleotide Polymorphisms both inside and outside the MHC region PMID: 22495925
  70. Neither univariate nor multivariate analysis showed any influence of HLA-E polymorphisms on the investigated endpoints of HSCT in our cohort. PMID: 22256791
  71. findings show that HLA-E/beta2m overexpression is a surrogate marker of poor prognosis and point to a novel mechanism of tumor immune escape in CRC in restraining inhibitory IEL-TIL PMID: 21953582
  72. Data suggest that the HLA-Ia reactivity of the anti-HLA-E antibody accounts for the non-donor-specific anti-HLA-Ia antibodies. PMID: 22190577
  73. There was a positive statistical correlation between the expression of HLA-E in neoplastic cells and the clinical stage of classical Hodgkin lymphoma PMID: 22177730
  74. Even in an admixed population such as the Brazilian one, the HLA-E locus is very conserved, presenting few polymorphic SNPs in the coding region. PMID: 22050290
  75. the consensus HLA-E-binding epitope within SP(UL40) was shown to promote cell surface expression of both HLA-E and gpUL1 PMID: 22345649
  76. These results suggest that HLA-E favors activating immune responses to colorectal carcinoma. PMID: 22032294
  77. initial evidence that the HLA-E molecule is enhanced by malignant transformation and is functional in tumor cells is presented PMID: 21969815
  78. The positive expression rate of MHC-I A/B and HLA-E in ALL patients was obviously higher than that in AML patients. PMID: 21518478
  79. sHLA-E concentration in synovial fluid correlates with the number of affected joints in patients with juvenile idiopathic arthritis. PMID: 21186170
  80. selenite induces an almost complete loss of cell surface loss of HLA-E expression on tumor cells which resulted in increased susceptibility to CD94/NK group 2A-positive NK cells PMID: 21890659
  81. the lack of association between HLA-E alleles and nasopharyngeal carcinoma PMID: 21332388
  82. High HLA-E is associated with hepatocellular carcinoma. PMID: 21744989
  83. HLA-E*0101 homozygosity may be a risk factor for recurrent miscarriage. PMID: 21410502
  84. We found the production of HLA-G and HLA-E in a majority of cases of glioblastoma PMID: 20667016
  85. an irradiation-induced, transient up-regulation of HLA-E on macrovascular ECs might confer protection against NK cell-mediated vascular injury PMID: 21179573
  86. This study confirmed a significant association between MHC region and psoriasis. More important, it provided evidence for interactions between MHC and LCE and between MHC and IL12B in determining the risk of psoriasis in Chinese population. PMID: 21208785
  87. Linkage disequilibrium between HLA-G*0104 and HLA-E*0103 alleles in Tswa Pygmies. PMID: 21299523
  88. HLA-E has a role in implantation via immunoregulation or modulation of uterine maternal leukocytes. PMID: 20113960
  89. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. PMID: 21057081
  90. HLA-E-restricted CD8(+) T cells may play an important role in keeping self-reactive T cells in check. PMID: 20877010
  91. The skeletal muscles of myasthenia gravis up regulation of MHC class I. PMID: 20546939
  92. The decreased expression of HLA-G and HLA-E may play a role in the pathogenesis of intrahepatic cholestasis of pregnancy. PMID: 17953356
  93. There is a strong association between the HLA-E functional polymorphism rs1264457 and ankylosing spondylitis PMID: 19912639
  94. We speculate that the expression of HLA-E by activated microglia/CNS macrophages plays a role in the anti-tumoral immunity in the development of glioblastoma. PMID: 20167379
  95. The expressions of HLA-G and -E mRNA in the spontaneous abortion group were much lower than those in the control group. PMID: 19253840
  96. Peptide binding specificity of HLA-E. PMID: 11432755
  97. Signal peptide processing by signal peptidase is essential in the generation of HLA-E-binding epitopes derived from the signal sequence of polymorphic MHC class I molecules. PMID: 11714810
  98. Soluble HLA-E tetramers refolded with different peptides (specifically stained K14 cells. HLA-E tetramer binding was reduced by pretreatment with anti-CD94 mAb alone, but was completely prevented in combination with anti-clonotypic mAb. PMID: 11920559
  99. expresssion modulates cytokine production of monocyte generated dendritic cells PMID: 12232815
  100. HLA-E allelic variants: differential expression, peptide affinities, crystal structures, and thermal stabilities. PMID: 12411439

Show More

Hide All

Subcellular Location Membrane, Single-pass type I membrane protein
Protein Families MHC class I family
Database Links

HGNC: 4962

OMIM: 143010

KEGG: hsa:3133

STRING: 9606.ENSP00000365817

UniGene: Hs.650174

Most popular with customers


Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2020 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1